{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:01:56Z","timestamp":1789794116011,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"DOI":"10.7759\/cureus.116513","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:16:21Z","timestamp":1789791381000},"source":"Crossref","is-referenced-by-count":0,"title":["Warfarin for Left Ventricular Thrombus in Nonischemic Cardiomyopathy With Acute Kidney Injury: A Case Report and Literature Review of Anticoagulation Strategies in Renal Impairment"],"prefix":"10.7759","author":[{"given":"Sean","family":"Pack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikramjit","family":"Chhokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine GN","year":"2022","unstructured":"Levine GN, McEvoy JW, Fang JC, et al.. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022, 146:e205-23. 10.1161\/CIR.0000000000001092","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.10.038","article-title":"When direct oral anticoagulants should not be standard treatment: JACC state-of-the-art review","volume":"83","author":"Bejjani A","year":"2024","unstructured":"Bejjani A, Khairani CD, Assi A, et al.. When direct oral anticoagulants should not be standard treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2024, 83:444-65. 10.1016\/j.jacc.2023.10.038","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami J","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JE, et al.. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019, 139:e840-78. 10.1161\/CIR.0000000000000664","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2267","article-title":"Direct oral anticoagulation versus warfarin in left ventricular thrombus: pooled analysis of randomized controlled trials","volume":"63","author":"Sahl\u00e9n AO","year":"2023","unstructured":"Sahl\u00e9n AO, Jiang H, Lau YH, et al.. Direct oral anticoagulation versus warfarin in left ventricular thrombus: pooled analysis of randomized controlled trials. J Clin Pharmacol. 2023, 63:1101-7. 10.1002\/jcph.2267","journal-title":"J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2024.09.008","article-title":"Direct oral anticoagulants versus vitamin K antagonists for the management of left ventricular thrombus after myocardial infarction: a meta-analysis","volume":"232","author":"Gogos C","year":"2024","unstructured":"Gogos C, Anastasiou V, Papazoglou AS, et al.. Direct oral anticoagulants versus vitamin K antagonists for the management of left ventricular thrombus after myocardial infarction: a meta-analysis. Am J Cardiol. 2024, 232:18-25. 10.1016\/j.amjcard.2024.09.008","journal-title":"Am J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14196735","article-title":"An updated meta-analysis of randomized controlled trials comparing direct oral anticoagulants against warfarin for left ventricular thrombus resolution","volume":"14","author":"Magdy J","year":"2025","unstructured":"Magdy J, He M, Arockiam S, Harada N, Wheatcroft SB, Bulluck H. An updated meta-analysis of randomized controlled trials comparing direct oral anticoagulants against warfarin for left ventricular thrombus resolution. J Clin Med. 2025, 14:6735. 10.3390\/jcm14196735","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101978","article-title":"Rivaroxaban vs warfarin in acute left ventricular thrombus following myocardial infarction: RIVAWAR, an open-label RCT","volume":"4","author":"Shah JA","year":"2025","unstructured":"Shah JA, Hussain J, Ahmed B, et al.. Rivaroxaban vs warfarin in acute left ventricular thrombus following myocardial infarction: RIVAWAR, an open-label RCT. JACC Adv. 2025, 4:101978. 10.1016\/j.jacadv.2025.101978","journal-title":"JACC Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao SV","year":"2025","unstructured":"Rao SV, O'Donoghue ML, Ruel M, et al.. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025, 151:e771-862. 10.1161\/CIR.0000000000001309","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs274","article-title":"Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"33","author":"Hohnloser SH","year":"2012","unstructured":"Hohnloser SH, Hijazi Z, Thomas L, et al.. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012, 33:2821-30. 10.1093\/eurheartj\/ehs274","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD","volume":"85","author":"Navaneethan SD","year":"2025","unstructured":"Navaneethan SD, Bansal N, Cavanaugh KL, et al.. KDOQI US commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2025, 85:135-76. 10.1053\/j.ajkd.2024.08.003","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"L\u00f6fman I","year":"2017","unstructured":"L\u00f6fman I, Szummer K, Dahlstr\u00f6m U, Jernberg T, Lund LH. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail. 2017, 19:1606-14. 10.1002\/ejhf.821","journal-title":"Eur J Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.11.007","article-title":"Outcomes of KDIGO-defined CKD in U.S. veterans with HFpEF, HFmrEF, and HFrEF","volume":"13","author":"Patel S","year":"2025","unstructured":"Patel S, Raman VK, Faselis C, et al.. Outcomes of KDIGO-defined CKD in U.S. veterans with HFpEF, HFmrEF, and HFrEF. JACC Heart Fail. 2025, 13:467-79. 10.1016\/j.jchf.2024.11.007","journal-title":"JACC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.05.002","article-title":"Kidney function and outcomes in patients hospitalized with heart failure","volume":"78","author":"Patel RB","year":"2021","unstructured":"Patel RB, Fonarow GC, Greene SJ, et al.. Kidney function and outcomes in patients hospitalized with heart failure. J Am Coll Cardiol. 2021, 78:330-43. 10.1016\/j.jacc.2021.05.002","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14520","article-title":"Incidence, mortality, and predictors of acute kidney injury in patients with heart failure: a systematic review","volume":"10","author":"Ru SC","year":"2023","unstructured":"Ru SC, Lv SB, Li ZJ. Incidence, mortality, and predictors of acute kidney injury in patients with heart failure: a systematic review. ESC Heart Fail. 2023, 10:3237-49. 10.1002\/ehf2.14520","journal-title":"ESC Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756197","article-title":"Risk factors for left ventricular thrombus formation in patients with dilated cardiomyopathy","volume":"49","author":"Wu HS","year":"2023","unstructured":"Wu HS, Dong JZ, Du X, et al.. Risk factors for left ventricular thrombus formation in patients with dilated cardiomyopathy. Semin Thromb Hemost. 2023, 49:673-8. 10.1055\/s-0042-1756197","journal-title":"Semin Thromb Hemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132329","article-title":"Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: a nationwide database analysis","volume":"411","author":"Fujino M","year":"2024","unstructured":"Fujino M, Aikawa H, Nakao K, et al.. Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: a nationwide database analysis. Int J Cardiol. 2024, 411:132329. 10.1016\/j.ijcard.2024.132329","journal-title":"Int J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeaa244","article-title":"Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy","volume":"22","author":"Hooks M","year":"2021","unstructured":"Hooks M, Okasha O, Velangi PS, Nijjar PS, Farzaneh-Far A, Shenoy C. Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2021, 22:1425-33. 10.1093\/ehjci\/jeaa244","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014-2020)","volume":"38","author":"Urbich M","year":"2020","unstructured":"Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS, Di Tanna GL. A systematic review of medical costs associated with heart failure in the USA (2014-2020). Pharmacoeconomics. 2020, 38:1219-36. 10.1007\/s40273-020-00952-0","journal-title":"Pharmacoeconomics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/514503-warfarin-for-left-ventricular-thrombus-in-nonischemic-cardiomyopathy-with-acute-kidney-injury-a-case-report-and-literature-review-of-anticoagulation-strategies-in-renal-impairment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:16:21Z","timestamp":1789791381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/514503-warfarin-for-left-ventricular-thrombus-in-nonischemic-cardiomyopathy-with-acute-kidney-injury-a-case-report-and-literature-review-of-anticoagulation-strategies-in-renal-impairment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.116513","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}